CLINICAL_TRIALS
trial_result
· 2012-03-08
Clinical Trial Update: Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia [Phase 2]
Summary
A Phase 2 trial evaluating the addition of sodium nitroprusside to treatment as usual in schizophrenia has completed, assessing the safety and efficacy of the a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sao Paulo | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED